References
B. Egan, G. Grassi, Sympathetic activation and endothelial dysfunction as therapeutic targets in obesity-related hypertension. J. Hypertens. 31(2), 259–260 (2013)
N.S. Lobato, F.P. Filgueira, E.H. Akamine, R.C. Tostes, M.H. Carvalho, Z.B. Fortes, Mechanisms of endothelial dysfunction in obesity-associated hypertension. Braz. J. Med. Biol. Res. 45(5), 392–400 (2012)
A. Stepanian, L. Bourguignat, S. Hennou et al., Microparticle increase in severe obesity: not related to metabolic syndrome and unchanged after massive weight loss. Obesity (Silver Spring). 21(11), 2236–2243 (2013)
C.M. Boulanger, Microparticles, vascular function and hypertension. Curr. Opin. Nephrol. Hypertens. 19(2), 177–180 (2010)
A.C. Vion, A.A. Birukova, C.M. Boulanger, K.G. Birukov, Mechanical forces stimulate endothelial microparticle generation via caspase-dependent apoptosis-independent mechanism. Pulm. Circ. 3(1), 95–99 (2013)
Acknowledgment
This study is project supported by the National Natural Science Foundation of China (Grant No. 11274046) & Peking Union Medical College Innovation Funding (No. 3332013021).
Conflict of interest
There is no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hu, SS., Zhang, HG., Zhang, QJ. et al. CD51+ endothelial microparticles as a biomarker of endothelial dysfunction in obese patients with hypertension. Endocrine 49, 283–285 (2015). https://doi.org/10.1007/s12020-014-0423-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-014-0423-7